24AUG

Chip firm OLIX prints $312m at $3.3bn

3 min read

16:40UTC

London inference-chip company OLIX confirmed a $312m Series B at a $3.3bn valuation, and quietly hired Wise's former finance chief to run its own books.

← Back to UKRI's sponsor department no longer exists Jump to analysis ↓

TechnologyDeveloping

Key takeaway

OLIX raised $312m at $3.3bn and hired Wise's IPO-era CFO two years before first silicon ships.

Olix, a London inference-chip company founded in 2024, confirmed a $312m Series B at a $3.3bn valuation on 3 August in its own release ¹. Arm, Fundomo and Hudson River Trading joined, Reed Hastings came in as an angel, and every existing backer increased its commitment. Inference chips run trained AI models rather than training them, a workload that now consumes most of the compute a deployed model ever uses.

Two appointments went unreported in the trade write-ups of the round. Nick McKeown, the Stanford professor who co-invented software-defined networking and won the 2025 Marconi Prize, joined the board. Matt Briers, chief financial officer (CFO) of Wise from 2015 through its 2021 London listing, took the same job at Olix. Hiring a CFO who has already taken a British technology company through a London IPO is a specific piece of forward planning, and it lands well before Olix's DX-1 decode accelerator reaches first customers in the second half of 2027.

Olix's own release and the government's release of the same date describe the round differently. The company names its new investors and does not mention state capital; gov.uk states that Olix is the fifth company to receive equity investment from the Sovereign AI Fund since it launched ². A company release is a marketing document rather than a share register, and omission from one carries no information about who holds the stock. CuspAI's July round listed the investor under its other label, Sovereign AI Unit .

Deep Analysis

In plain English

OLIX is a London company building a specialised computer chip, the kind used to run trained AI models quickly and cheaply, called an inference chip. This is different from the chips used to train AI models in the first place; Nvidia dominates that market, and companies like OLIX are betting the market for running those models will grow even bigger. OLIX raised $312m from investors, valuing the company at $3.3bn. Big names joined: Arm, the Cambridge company whose chip designs sit inside most smartphones, and Reed Hastings, the co-founder of Netflix, investing his own money rather than through a fund. OLIX also hired two experienced people: a Stanford professor who helped invent a major networking technology, and the former finance chief of Wise, the money-transfer company that listed in London in 2021. The catch: OLIX's actual chip, the DX-1, will not reach its first paying customers until the second half of 2027. Investors are paying a $3.3bn price today for a product that has not yet been tested by anyone outside the company.

Deep Analysis

Root Causes

OLIX's valuation rests on a structural bet common to inference-chip start-ups: training chips, Nvidia's dominant market, and inference chips, running trained models cheaply at volume, are different economics, and investors are pricing the second market on the assumption that inference workload will outgrow training workload as AI models move from being built to being used.

Callosum's $100m raise six days later, covered elsewhere in this briefing, shows capital consolidating in AI infrastructure rather than spreading across sectors, the same pattern Index Ventures backed in Conduct's round the previous month .

Reed Hastings investing personally, rather than through a fund, removes the diligence layer a venture partnership would normally apply, and increases the share of the round priced on reputation rather than technical benchmarking.

What could happen next?

Risk
OLIX's $3.3bn valuation is being paid before any customer outside the company has benchmarked the DX-1 chip, which does not ship until the second half of 2027.
Meaning
Arm and Hudson River Trading joining from opposite ends of the compute supply chain signals investor confidence that inference demand will outpace training demand.

Source Landscape

This story draws on neutral-leaning sources

Primary parallel: Graphcore, the Bristol AI-chip company, raised at a $2.8bn valuation in 2020 on the strength of its architecture before any high-volume customer had shipped product on it; the valuation proved harder to sustain than the funding round, and SoftBank acquired Graphcore in 2024 at a fraction of its peak mark.

Counter-parallel: Arm itself followed the opposite path from Cambridge: it built licensing revenue for over a decade before going public in 2023, by which point its chip architecture was already inside the large majority of the world's mobile devices. Olix is closer to Graphcore's starting position, pre-revenue at scale, than to Arm's.

Consensus view: Arm, the Cambridge chip-design licensor that already earns royalties on the processors most AI accelerators pair with, and Hudson River Trading, a quantitative trading firm that buys compute rather than sells it, both joined Olix's round, a combination that reads as a bet on inference-chip demand from two very different points in the same supply chain.

Counter-view: No published third-party analysis of Olix's technical roadmap turned up in the sources for this briefing. The unattributed risk worth naming: the DX-1 decode accelerator does not reach first customers until the second half of 2027, more than a year after this round closed, so the $3.3bn valuation is being paid for a chip nobody outside the company has yet benchmarked.

Key tension: Whether Olix's board additions, Stanford's Nick McKeown for technical credibility and Wise's former CFO Matt Briers for listing discipline, signal a company preparing to ship on schedule or one preparing for scrutiny it expects before it does.

Sources:OLIX

Mentions:Olix →Arm →Nvidia →CuspAI →London →SoftBank →Sovereign AI Unit →Bristol →Netflix →Cambridge →

First Reported In

Update #14 · UKRI's sponsor department no longer exists

OLIX· 24 Aug 2026

Read original →

Different Perspectives

Highland Europe

Highland Europe, the growth-equity firm behind a €1bn-plus fund, took €65m from the British Business Bank into its Technology Growth Fund VI on 30 July via British Patient Capital. For a Geneva-based growth investor, the Bank's cheque is routine cornerstone capital, unrelated to which Whitehall department currently claims to sponsor UKRI.

Integrity Growth Partners

The Los Angeles firm put £16.1m into Prevalent AI on 24 August, the London GCHQ-alumni company's first outside capital, specifically to fund its US expansion. Its stake is a single commercial bet on one UK deep-tech founder's American growth, not a comment on which department UKRI answers to this month.

Temasek

Temasek led PhysicsX's Series C on 30 July, into which the British Business Bank put $25m through British Growth Partnership Fund I. State-backed pension capital rides behind a foreign-led growth round while UK weekly tech funding fell 72% to £102.95m across nine rounds three weeks later.

Innovate UK's Women in Innovation cohort

Sixty-one founders won £75,000 grants from Innovate UK on 5 August, the programme's largest-ever cohort, with a further 39 highly commended founders taking support without cash. For these founders the sponsorship dispute over UKRI's parent department is academic: the money and mentoring arrived exactly as scheduled.

Financial Conduct Authority

The FCA added five fintechs, ClearScore, Modulr, Teya, Urban Jungle and Zilch, to its Scale-up Unit on 7 August, the first cohort it regulates solely rather than jointly with the Prudential Regulation Authority. The unit's expansion is a routine regulatory build-out running on its own timetable, unconnected to the sponsorship dispute over its sister department UKRI.

Cabinet Office

The Cabinet Office ran the DSIT-to-BIST transfer as a standard cross-government machinery change, the kind gov.uk pages and framework documents routinely take months to catch up with after any department is abolished or renamed. Officials treat the paperwork lag as administrative sequencing, not dysfunction: funding and grant-approval layers moved first because they had to keep working.